(Q35552265)

English

Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

scientific article published on December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

0 references

Gerd-Rüdiger Burmester

9

object named as

G R Burmester

1 reference

Europe PubMed Central

8 August 2017

author name string

L B A van de Putte

1

1 reference

Europe PubMed Central

8 August 2017

R Rau

2

1 reference

Europe PubMed Central

8 August 2017

F C Breedveld

3

1 reference

Europe PubMed Central

8 August 2017

J R Kalden

4

1 reference

Europe PubMed Central

8 August 2017

M G Malaise

5

1 reference

Europe PubMed Central

8 August 2017

P L C M van Riel

6

1 reference

Europe PubMed Central

8 August 2017

M Schattenkirchner

7

1 reference

Europe PubMed Central

8 August 2017

H Zeidler

10

1 reference

Europe PubMed Central

8 August 2017

H M Moutsopoulos

11

1 reference

Europe PubMed Central

8 August 2017

K Beck

12

1 reference

Europe PubMed Central

8 August 2017

H Kupper

13

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

8 August 2017

62

1 reference

Europe PubMed Central

8 August 2017

1168-1177

1 reference

Europe PubMed Central

8 August 2017

12

1 reference

Europe PubMed Central

8 August 2017

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcore

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Rheumatoid arthritis: guidelines for emerging therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

How is it best to treat early rheumatoid arthritis patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Prospects for autoimmune disease: Research advances in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

The existence of geographical clusters of cases of inflammatory polyarthritis in a primary care based register

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Towards a network theory of the immune system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Long-term outcome of treating rheumatoid arthritis: results after 20 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

27 July 2018

Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

26 September 2018

Epidemiology of rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

26 September 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

26 September 2018

Role of cytokines in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

26 September 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

26 September 2018

Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754401

26 September 2018

Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid profiles in untreated patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of rheumatoid arthritis and musculoskeletal diseases in the elderly population

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of functional capacity caused by a delayed onset of DMARD therapy in rheumatoid arthritis. Long-term follow-up results of the Keitel function test. Brief definite report

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14644854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2003.009563

1 reference

Europe PubMed Central

8 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35552265&oldid=1647876927"